62,734
edits
Changes
no edit summary
| 2005 || Publication || {{w|Hospital-acquired infection}} || The {{w|American Thoracic Society}} and {{w|Infectious Diseases Society of America}} publish guidelines suggesting antibiotics specifically for {{w|hospital-acquired pneumonia}}.<ref name="guidelines">{{cite journal |author=American Thoracic Society |author2=Infectious Diseases Society of America |title=Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia |journal=Am. J. Respir. Crit. Care Med. |volume=171 |issue=4 |pages=388–416 |year=2005 |pmid=15699079 |doi=10.1164/rccm.200405-644ST|url=https://semanticscholar.org/paper/c1e3c150b88a50d40302f15a5533bdd6b0da5885 }}</ref> || {{w|United States}}
|-
| 2005 || Organization || || The {{w|International Rectal Microbicide Advocates}} is founded. Based in {{w|Chicago}}, it is a global network of advocates, policymakers and scientists working to advance a robust rectal microbicide research and development agenda.<ref>{{cite web |title=IRMA |url=https://rectalmicrobicides.org/#:~:text=Get%20in%20Touch-,IRMA,microbicide%20research%20and%20development%20agenda. |website=rectalmicrobicides.org |accessdate=11 July 2020}}</ref> ||{{w|United States}}
|-
| 2006 || Organization || HIV infection || The {{w|Microbicide Trials Network}} is established by the U.S. {{w|National Institute of Allergy and Infectious Diseases}} as an HIV/AIDS clinical trials network. It focuses on research into {{w|microbicide}}s aimed at preventing HIV infection.<ref>{{cite web |title=MTN |url=https://mtnstopshiv.org/about-us |website=mtnstopshiv.org |accessdate=11 July 2020}}</ref> || {{w|United States}}
